4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]-amino]-3-fluorophenoxyl]-N-methyl-2-pyridinecarboxamide, p-toluenesulfonate salt | |
---|---|
Trade Name | |
Orphan Indication | Chronic myeloid leukemia |
USA Market Approval | USA |
USA Designation Date | 2009-09-03 00:00:00 |
Sponsor | Deciphera Pharmaceuticals, LLC;643 Massachusetts, Suite 200;Lawrence, Kansas, 66044 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia